JP2004500321A5 - - Google Patents

Download PDF

Info

Publication number
JP2004500321A5
JP2004500321A5 JP2000606604A JP2000606604A JP2004500321A5 JP 2004500321 A5 JP2004500321 A5 JP 2004500321A5 JP 2000606604 A JP2000606604 A JP 2000606604A JP 2000606604 A JP2000606604 A JP 2000606604A JP 2004500321 A5 JP2004500321 A5 JP 2004500321A5
Authority
JP
Japan
Prior art keywords
reversible
dose
washing
application
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000606604A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004500321A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2000/000294 external-priority patent/WO2000056743A1/en
Publication of JP2004500321A publication Critical patent/JP2004500321A/ja
Publication of JP2004500321A5 publication Critical patent/JP2004500321A5/ja
Withdrawn legal-status Critical Current

Links

JP2000606604A 1999-03-19 2000-03-17 金属錯体を含む薬学的組成物 Withdrawn JP2004500321A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12516699P 1999-03-19 1999-03-19
PCT/CA2000/000294 WO2000056743A1 (en) 1999-03-19 2000-03-17 Pharmaceutical compositions comprising metal complexes

Publications (2)

Publication Number Publication Date
JP2004500321A JP2004500321A (ja) 2004-01-08
JP2004500321A5 true JP2004500321A5 (cg-RX-API-DMAC7.html) 2004-12-24

Family

ID=22418482

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000606604A Withdrawn JP2004500321A (ja) 1999-03-19 2000-03-17 金属錯体を含む薬学的組成物

Country Status (15)

Country Link
US (1) US20020049190A1 (cg-RX-API-DMAC7.html)
EP (1) EP1163247A1 (cg-RX-API-DMAC7.html)
JP (1) JP2004500321A (cg-RX-API-DMAC7.html)
KR (1) KR20010112343A (cg-RX-API-DMAC7.html)
CN (1) CN1391577A (cg-RX-API-DMAC7.html)
AU (1) AU3268500A (cg-RX-API-DMAC7.html)
BR (1) BR0011678A (cg-RX-API-DMAC7.html)
CA (1) CA2367282A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20013307A3 (cg-RX-API-DMAC7.html)
HU (1) HUP0400457A2 (cg-RX-API-DMAC7.html)
IL (1) IL145290A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA01009410A (cg-RX-API-DMAC7.html)
NO (1) NO20014526L (cg-RX-API-DMAC7.html)
PL (1) PL356683A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000056743A1 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60023859T2 (de) 1999-04-13 2006-08-03 Anormed Inc., Langley Verfahren zur herstellung von amin-platin-komplexen
JP4227701B2 (ja) * 1999-05-25 2009-02-18 中部キレスト株式会社 ジエチレントリアミン五酢酸ルテニウム二アンモニウム塩またはその水和物およびその製法
US6489638B2 (en) * 2000-06-23 2002-12-03 Semiconductor Energy Laboratory Co., Ltd. Light emitting device
US6894049B1 (en) 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
US20020072512A1 (en) * 2000-12-08 2002-06-13 Metaphore Pharmaceuticals, Inc Method of preventing and treating HIV-mediated central nervous system damage
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
RU2004126950A (ru) 2002-02-04 2005-06-27 АЛФАМА-Инвестигасау и Дезенволвименту де Продутош Фармасеутикуш Лда. (PT) Использование выделяющих co соединений при изготовлении лекарственного средства для лечения воспалительных заболеваний
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
GB2395431A (en) * 2002-11-20 2004-05-26 Northwick Park Inst For Medica Combination of a metal carbonyl compound and a guanylate cyclase stimulant or stabilizer for the therapeutic delivery of carbon monoxide
US7737179B2 (en) * 2003-08-04 2010-06-15 J&J Consumer Companies, Inc. Methods for treatment of dermatological conditions
KR101130433B1 (ko) 2004-02-05 2012-03-27 교린 세이야꾸 가부시키 가이샤 비시클로에스테르 유도체
FR2873037B1 (fr) * 2004-07-13 2008-04-11 Univ Pasteur Methodes et compositions pour le traitement de cancers
EP2447271A1 (en) * 2005-12-21 2012-05-02 F. Hoffmann-La Roche AG Redox mediators
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
EP1995237A4 (en) 2006-03-08 2011-07-06 Kyorin Seiyaku Kk PROCESS FOR PREPARING AN AMINOACETYLPYRROLIDINCARBONITRILE DERIVATIVE AND PRODUCTION PRODUCT THEREOF
CA2655933C (en) 2006-06-23 2014-09-09 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
WO2008038305A2 (en) * 2006-09-26 2008-04-03 Jegannathan Srinivas Therapeutical formulation comprising a thiazolidinedione and a nitric oxide scavenger.
JPWO2008114857A1 (ja) 2007-03-22 2010-07-08 杏林製薬株式会社 アミノアセチルピロリジンカルボニトリル誘導体の製造方法
CA3050455A1 (en) 2008-11-03 2010-06-03 Adc Therapeutics Sa Antibodies that specifically block the biological activity of a tumor antigen
DE102010014412A1 (de) 2010-04-08 2012-04-19 Friedrich-Schiller-Universität Jena Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe
DE102010014411A1 (de) 2010-04-08 2011-10-13 Friedrich-Schiller-Universität Jena Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung
DK3173427T3 (da) 2011-03-31 2019-08-05 Adc Therapeutics Sa Antistoffer mod nyre-associeret antigen 1 og antigen-bindende fragmenter deraf
JP5978291B2 (ja) 2011-04-19 2016-08-24 アルファーマ インコーポレイテッドAlfama,Inc. 一酸化炭素放出分子およびその使用
EP2734235B1 (en) 2011-07-21 2017-03-22 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
IN2014CN04690A (cg-RX-API-DMAC7.html) 2012-01-09 2015-09-18 Alethia Biotherapeutics Inc
DE102012004132A1 (de) 2012-02-29 2013-08-29 Friedrich-Schiller-Universität Jena Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung
DE102014008537A1 (de) 2014-06-04 2015-12-17 Friedrich-Schiller-Universität Jena Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung
US11420910B2 (en) * 2014-10-30 2022-08-23 Katholieke Universitet Leuven Methods for low temperature fluorine-18 radiolabeling of biomolecules
CN113429456B (zh) * 2021-06-11 2022-05-31 首都医科大学 多肽衍生物钌类络合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112974A (en) * 1985-01-18 1992-05-12 The Trustees Of Columbia University In The City Of New York Mixed ligand complexes and uses thereof as binding agents to DNA
US4721669A (en) * 1985-01-18 1988-01-26 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents
GB9317686D0 (en) * 1993-08-25 1993-10-13 Johnson Matthey Plc Pharmaceutical compositions
SE9703396D0 (sv) * 1997-09-19 1997-09-19 Lincoln Binuclear complex

Similar Documents

Publication Publication Date Title
JP2004500321A5 (cg-RX-API-DMAC7.html)
EE200300236A (et) 1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod
JP2004502858A5 (cg-RX-API-DMAC7.html)
CY2012032I2 (el) Ενωσεις 1,2-διυδροπυριδινης, διεργασια για την παρασκευη των ιδιων και χρηση εξ αυτων
DE50313653D1 (de) Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel
JP2006516140A5 (cg-RX-API-DMAC7.html)
EE04879B1 (et) Sünteetilised pindaktiivsed peptiidid ja nende kasutamine sünteetilise surfaktandi valmistamiseks
JP2002542199A5 (cg-RX-API-DMAC7.html)
JP2006507281A5 (cg-RX-API-DMAC7.html)
EE200300171A (et) Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
JP2003520017A5 (cg-RX-API-DMAC7.html)
DE60108100D1 (de) Filmsubstrate mit innewohnenden tintenempfänglichen eigenschaften und deren herstellungsverfahren
DE60023103D1 (de) Lüfter und dessen Herstellungverfahren
BRPI0405450A (pt) Agente de revestimento
DE60131663D1 (de) Acylacetonitrile, deren herstellung und diese enthaltende miticide
DE60014694D1 (de) Poröser silikatischer film mit niedriger durchlässigkeit, halbleiterelement mit solchem film, und beschichtungszusammensetzung den film bildend
JP2003515534A5 (cg-RX-API-DMAC7.html)
JP2003528985A5 (cg-RX-API-DMAC7.html)
JP2000028062A5 (cg-RX-API-DMAC7.html)
DE60200719D1 (de) Filmbildende Zusammensetzung, poröser Film und deren Herstellung
JP2002022755A5 (cg-RX-API-DMAC7.html)
FI20000818A0 (fi) Dermatologinen käyttö ja valmiste
NL1013684A1 (nl) Verknopingsmiddel voor fotolaklaag, en fotolaklaagsamenstelling welke dezelfde omvat.
JPH11148936A5 (cg-RX-API-DMAC7.html)
DE60144265D1 (de) Halbleiterbauelement und dessen herstelllung